Valeant

Page 10 of 12

Oil Glut and Valeant Talks With Investors–5 Things To Know Today
Retail

Oil Glut and Valeant Talks With Investors–5 Things To Know Today

By Laura Lorenzetti and Geoffrey Smith
November 10, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Here’s Why Valeant CEO Michael Pearson’s Stock Sale Matters

By
November 6, 2015
ENRON BANKRUPTCY
Finance

Valeant: Why Enron-era accounting never really died with Enron

By
November 2, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, Quebec
Health

Valeant: A timeline of the big Pharma scandal

By
October 31, 2015
Key Speakers At The 20th Annual Sohn Investment Conference
Finance

Bill Ackman thought Valeant was the next Berkshire Hathaway

By
October 30, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

The stock that ate Wall Street

By
October 30, 2015
Hedge fund manager Bill Ackman
Finance

Bill Ackman on Valeant: ‘Life will go on’

By
October 30, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health

Valeant cuts ties to controversial pharmacy chain Philidor

By
October 30, 2015
Hedge fund manager Bill Ackman
Finance

Another one of Bill Ackman’s top stocks is down 50%

By
October 29, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant accounting scandal: 4 critical questions that have been left unanswered

By
October 26, 2015
Hedge fund manager Bill Ackman
Finance

What the drop in Valeant’s stock says about hedge funds’ herd mentality

By
October 25, 2015
Imprimis Turing Drug
Health

This company is offering a $1 alternative to Turing’s $750 drug

By
October 23, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant short seller on pharmacy alliance: It’s the ‘turd in the punch bowl’

By
October 22, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance

Valeant’s accounting problems: It gets worse

By
October 22, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Forget the plunging stock price, here’s Valeant’s biggest problem

By
October 22, 2015

Most Popular